On Thursday, Shares of Equifax Inc. (NYSE:EFX), gained 4.47% to $98.40, hitting its highest level.
Equifax, declared financial results for the quarter ended March 31, 2015.
Financial Results Summary
The company stated revenue of $651.8 million in the first quarter of 2015, a 12 percent enhance from the first quarter of 2014 on a stated basis and 14 percent in local currency. Adjusted EPS attributable to Equifax was $1.07, up 20 percent from the first quarter of 2014, after adjusting for a charge related predominantly to the realignment of internal resources, in addition to acquisition-related amortization expense. Diluted EPS attributable to Equifax was $0.73, up 9 percent from the first quarter of 2014. Adjusted operating margin was 27.2 percent, up 120 points from the first quarter of 2014, after adjusting for a charge related predominantly to the realignment of internal resources. Operating margin was 23.7 percent, down 230 basis points from the first quarter of 2014.
Equifax Inc. provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers.
Shares of Carlisle Companies Incorporated (NYSE:CSL), gained 4.45% to $99.08, during its last trading session, hitting its highest level.
Carlisle Companies, stated net sales from ongoing operations of $709.3 million for the quarter ended March 31, 2015, a 9.1% enhance from $650.4 million in the first quarter 2014. Organic net sales (defined as net sales not taking into account sales from acquisition and divestitures within the last twelve months, in addition to the impact of changes in foreign exchange rates) growth was 7.4%. The acquisition of LHi Technology (LHi) in the Carlisle Interconnect Technologies (CIT) segment contributed 3.9% to net sales in the first quarter. Fluctuations from foreign exchange had a negative impact to net sales of 2.2%.
Income from ongoing operations in the first quarter 2015 raised 8.2% to $39.5 million, contrast with $36.5 million in the first quarter 2014, reflecting higher sales volume and savings from the Carlisle Operating System, partially offset by the negative impact of unfavorable changes in sales mix, fluctuations in foreign exchange and lower earnings at Carlisle FoodService Products (CFS). On a per share basis, income from ongoing operations in the first quarter 2015 raised 5.4% to $0.59 per diluted share, from $0.56 per diluted share in the preceding year.
Carlisle Companies Incorporated operates as a diversified manufacturing company in the United States and internationally. The company’s Construction Materials segment manufactures and sells rubber, thermoplastic polyolefin, polyvinyl chloride membrane roofing systems.
At the end of Thursday’s trade, Shares of Boston Private Financial Holdings, Inc. (NASDAQ:BPFH), gained 4.24% to $13.03.
Boston Private Financial Holdings, declared a number of new senior executive appointments and leadership assignments. These changes will align more directly the Boston Private executive team with execution of the Company’s plan to become nationally recognized as a distinctive Wealth Administration, Trust and Private Banking organization. The Company is presently organized around four operating segments: Boston Private Wealth Administration and Trust, Boston Private Bank, Investment Administration, and Wealth Advisory.
Clayton G. Deutsch will continue as Chief Executive Officer of the Company and focus on corporate strategy, Company performance, and development of the Company’s portfolio of businesses across its key operating segments. Mr. Deutsch stated, “For the next several years I am fully committed to the accelerated development of our national expansion strategy. I believe the following executive appointments will better enable us to achieve this end.”
Mark D. Thompson has been designated President of the Company, and will continue to serve as Chief Executive Officer of Boston Private Bank, overseeing Boston Private Wealth and Boston Private Bank, and an expanded set of Wealth Administration, Trust and Private Banking capabilities under the Boston Private umbrella. In addition, Mr. Thompson will join the Company’s Board of Directors. Following their election at the Annual Shareholders Meeting tomorrow, Mr. Deutsch and Mr. Thompson will be the two Boston Private executives serving as Board members together with seven independent Directors with a non-executive Chair. Mr. Thompson joined the Company in 1994, and has served as CEO of Boston Private Bank since 2003. In partnership with Mr. Deutsch, Mr. Thompson will lead the development and expansion of Boston Private’s integrated Wealth Administration, Trust and Private Banking model across multiple geographic markets.
David J. Kaye has been designated the Company’s Chief Administrative Officer and will continue to serve as the Company’s Chief Financial Officer and Treasurer. Mr. Kaye will focus on ongoing to enhance the quality, effectiveness and efficiency of corporate functions and will work closely with Human Resources, Legal, Risk, Finance, Audit and Compliance, Investor Relations and corporate staff. Mr. Kaye joined the Company as CFO in 2007.
Boston Private Financial Holdings, Inc. operates as the bank holding company for Boston Private Bank & Trust Company that provides a range of banking and wealth administration services.
Finally, Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), ended its last trade with 4.17% gain, and closed at $9.61, hitting its highest level.
ARIAD Pharmaceuticals, declared that it will report its first quarter 2015 financial results on Thursday, May 7, 2015, before the market opens. Following the declaration, at 8:30 a.m. Eastern Time, company administration will host a conference call and webcast discussion of the results and provide a general corporate update.
ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
